Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  Ad5CMV-p53 gene
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-11 of 11 for your search:
Start Over
Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02541, MDA-ID-00193, P50CA097007, CDR0000306522, NCI-6053, 6053, NCT00064103
Gene Therapy in Treating Patients With Advanced Bladder Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02261, MDA-DM-96172, R21CA076233, CDR0000065968, NCI-T96-0073, T96-0073, NCT00003167
Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: NCI-2012-02273, FCCC-97009, NCI-T97-0042, CDR0000066480, T97-0042, NCT00004038
Gene Therapy in Treating Patients With Ovarian Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02277, MDA-ID-97228, NCI-T97-0111, CDR0000066657, T97-0111, NCT00003588
Gene Therapy in Treating Patients With Non-Small Cell Lung Cancer That Cannot Be Surgically Removed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066741, E-6597, NCT00003649
Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066871, NABTC-9703, NCT00004041
Phase I Pilot Study of Adenovirus p53 Gene Therapy and Radiotherapy in Patients With Non-Small Cell Lung Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-8597, E8597, NCT00004225
Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066481, UTSMC-089733300, NCI-T97-0096, T97-0096, NCT00003450
Start Over